337 related articles for article (PubMed ID: 19262111)
1. A role for the NG2 proteoglycan in glioma progression.
Stallcup WB; Huang FJ
Cell Adh Migr; 2008; 2(3):192-201. PubMed ID: 19262111
[TBL] [Abstract][Full Text] [Related]
2. Asymmetry-defective oligodendrocyte progenitors are glioma precursors.
Sugiarto S; Persson AI; Munoz EG; Waldhuber M; Lamagna C; Andor N; Hanecker P; Ayers-Ringler J; Phillips J; Siu J; Lim DA; Vandenberg S; Stallcup W; Berger MS; Bergers G; Weiss WA; Petritsch C
Cancer Cell; 2011 Sep; 20(3):328-40. PubMed ID: 21907924
[TBL] [Abstract][Full Text] [Related]
3. PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2.
Terrile M; Appolloni I; Calzolari F; Perris R; Tutucci E; Malatesta P
BMC Cancer; 2010 Oct; 10():550. PubMed ID: 20939912
[TBL] [Abstract][Full Text] [Related]
4. CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma.
Wiranowska M; Ladd S; Smith SR; Gottschall PE
Brain Cell Biol; 2006 Jun; 35(2-3):159-72. PubMed ID: 17957481
[TBL] [Abstract][Full Text] [Related]
5. The NG2 proteoglycan: past insights and future prospects.
Stallcup WB
J Neurocytol; 2002; 31(6-7):423-35. PubMed ID: 14501214
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of interaction between NG2 proteoglycan and galectin-3.
Wen Y; Makagiansar IT; Fukushi J; Liu FT; Fukuda MN; Stallcup WB
J Cell Biochem; 2006 May; 98(1):115-27. PubMed ID: 16365873
[TBL] [Abstract][Full Text] [Related]
7. The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.
Chekenya M; Enger PØ; Thorsen F; Tysnes BB; Al-Sarraj S; Read TA; Furmanek T; Mahesparan R; Levine JM; Butt AM; Pilkington GJ; Bjerkvig R
Neuropathol Appl Neurobiol; 2002 Oct; 28(5):367-80. PubMed ID: 12366818
[TBL] [Abstract][Full Text] [Related]
8. Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration.
Makagiansar IT; Williams S; Mustelin T; Stallcup WB
J Cell Biol; 2007 Jul; 178(1):155-65. PubMed ID: 17591920
[TBL] [Abstract][Full Text] [Related]
9. Interaction of syntenin-1 and the NG2 proteoglycan in migratory oligodendrocyte precursor cells.
Chatterjee N; Stegmüller J; Schätzle P; Karram K; Koroll M; Werner HB; Nave KA; Trotter J
J Biol Chem; 2008 Mar; 283(13):8310-7. PubMed ID: 18218632
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma.
Yadavilli S; Scafidi J; Becher OJ; Saratsis AM; Hiner RL; Kambhampati M; Mariarita S; MacDonald TJ; Codispoti KE; Magge SN; Jaiswal JK; Packer RJ; Nazarian J
Oncotarget; 2015 May; 6(14):12141-55. PubMed ID: 25987129
[TBL] [Abstract][Full Text] [Related]
11. A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen.
Burg MA; Nishiyama A; Stallcup WB
Exp Cell Res; 1997 Aug; 235(1):254-64. PubMed ID: 9281375
[TBL] [Abstract][Full Text] [Related]
12. Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface.
Nishiyama A; Stallcup WB
Mol Biol Cell; 1993 Nov; 4(11):1097-108. PubMed ID: 8305732
[TBL] [Abstract][Full Text] [Related]
13. Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord.
Kucharova K; Chang Y; Boor A; Yong VW; Stallcup WB
J Neuroinflammation; 2011 Nov; 8():158. PubMed ID: 22078261
[TBL] [Abstract][Full Text] [Related]
14. Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas.
Mellai M; Annovazzi L; Bisogno I; Corona C; Crociara P; Iulini B; Cassoni P; Casalone C; Boldorini R; Schiffer D
Cells; 2020 Jun; 9(6):. PubMed ID: 32599896
[TBL] [Abstract][Full Text] [Related]
15. NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.
Stallcup WB; You WK; Kucharova K; Cejudo-Martin P; Yotsumoto F
Microcirculation; 2016 Feb; 23(2):122-33. PubMed ID: 26465118
[TBL] [Abstract][Full Text] [Related]
16. The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelination.
Kucharova K; Stallcup WB
Neuroscience; 2010 Mar; 166(1):185-94. PubMed ID: 20006679
[TBL] [Abstract][Full Text] [Related]
17. The NG2 Proteoglycan in Pericyte Biology.
Stallcup WB
Adv Exp Med Biol; 2018; 1109():5-19. PubMed ID: 30523586
[TBL] [Abstract][Full Text] [Related]
18. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
[TBL] [Abstract][Full Text] [Related]
19. The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2.
Maus F; Sakry D; Binamé F; Karram K; Rajalingam K; Watts C; Heywood R; Krüger R; Stegmüller J; Werner HB; Nave KA; Krämer-Albers EM; Trotter J
PLoS One; 2015; 10(9):e0137311. PubMed ID: 26340347
[TBL] [Abstract][Full Text] [Related]
20. NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.
You WK; Yotsumoto F; Sakimura K; Adams RH; Stallcup WB
Angiogenesis; 2014 Jan; 17(1):61-76. PubMed ID: 23925489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
